Literature DB >> 18963540

Lacrimal gland radiosensitivity in uveal melanoma patients.

Karin Muller1, Peter J C M Nowak, Nicole Naus, Connie de Pan, Cornelis A van Santen, Peter Levendag, Gré P M Luyten.   

Abstract

PURPOSE: To find a dose-volume effect for inhomogeneous irradiated lacrimal glands. METHODS AND MATERIALS: Between 1999 and 2006, 72 patients (42 men and 30 women) were treated with fractionated stereotactic radiotherapy in a prospective, nonrandomized clinical trial (median follow-up, 32 months). A total dose of 50 Gy was given on 5 consecutive days. The mean of all Schirmer test results obtained > or =6 months after treatment was correlated with the radiation dose delivered to the lacrimal gland. Also, the appearance of dry eye syndrome (DES) was related to the lacrimal gland dose distribution.
RESULTS: Of the 72 patients, 17 developed a late Schirmer value <10 mm; 9 patients developed DES. A statistically significant relationship was found between the received median dose in the lacrimal gland vs. reduced tear production (p = 0.000) and vs. the appearance of DES (p = 0.003), respectively. A median dose of 7 Gy/fraction to the lacrimal gland caused a 50% risk of low Schirmer results. A median dose of 10 Gy resulted in a 50% probability of DES.
CONCLUSION: We found a clear dose-volume relationship for irradiated lacrimal glands with regard to reduced tear production and the appearance of DES.

Entities:  

Mesh:

Year:  2008        PMID: 18963540     DOI: 10.1016/j.ijrobp.2008.08.010

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  2 in total

1.  Clinical-dosimetric relationship between lacrimal gland dose and ocular toxicity after intensity-modulated radiotherapy for sinonasal tumours.

Authors:  S S Batth; R Sreeraman; E Dienes; L A Beckett; M E Daly; J Cui; M Mathai; J A Purdy; A M Chen
Journal:  Br J Radiol       Date:  2013-10-28       Impact factor: 3.039

2.  Feasibility study of a non-invasive eye fixation and monitoring device using a right-angle prism mirror for intensity-modulated radiotherapy for choroidal melanoma.

Authors:  Toshihiko Inoue; Norihisa Masai; Hiroya Shiomi; Ryoong-Jin Oh; Kenji Uemoto; Noriyasu Hashida
Journal:  J Radiat Res       Date:  2017-05-01       Impact factor: 2.724

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.